Prins RM - Search Results

1

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.

Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM, Kawaguchi ES, Du L, Li G, Yong WH, Gaffey SC, Cohen AL, Mellinghoff IK, Lee EQ, Reardon DA, O'Brien BJ, Butowski NA, Nghiemphu PL, Clarke JL, Arrillaga-Romany IC, Colman H, Kaley TJ, de Groot JF, Liau LM, Wen PY, Prins RM. Cloughesy TF, et al. Among authors: prins rm. Nat Med. 2019 Mar;25(3):477-486. doi: 10.1038/s41591-018-0337-7. Epub 2019 Feb 11. Nat Med. 2019. PMID: 30742122 Free PMC article. Clinical Trial.

2

Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.

Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP, Bronstein JM. Liau LM, et al. Among authors: prins rm. J Neurosurg. 1999 Jun;90(6):1115-24. doi: 10.3171/jns.1999.90.6.1115. J Neurosurg. 1999. PMID: 10350260

3

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.

Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM, Black KL. Yu JS, et al. Among authors: prins rm. Cancer Res. 2001 Feb 1;61(3):842-7. Cancer Res. 2001. PMID: 11221866 Clinical Trial.

4

Immunology and immunotherapy in neurosurgical disease.

Prins RM, Liau LM. Prins RM, et al. Neurosurgery. 2003 Jul;53(1):144-52; discussion 152-3. doi: 10.1227/01.neu.0000068865.34216.3a. Neurosurgery. 2003. PMID: 12823883 Review.

5

Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.

Prins RM, Odesa SK, Liau LM. Prins RM, et al. Cancer Res. 2003 Dec 1;63(23):8487-91. Cancer Res. 2003. PMID: 14679014

6

Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme.

Yang I, Kremen TJ, Giovannone AJ, Paik E, Odesa SK, Prins RM, Liau LM. Yang I, et al. Among authors: prins rm. J Neurosurg. 2004 Feb;100(2):310-9. doi: 10.3171/jns.2004.100.2.0310. J Neurosurg. 2004. PMID: 15086239

7

Cellular immunity and immunotherapy of brain tumors.

Prins RM, Liau LM. Prins RM, et al. Front Biosci. 2004 Sep 1;9:3124-36. doi: 10.2741/1465. Front Biosci. 2004. PMID: 15353342 Review.

8

Bioluminescent imaging of melanoma in live mice.

Craft N, Bruhn KW, Nguyen BD, Prins R, Liau LM, Collisson EA, De A, Kolodney MS, Gambhir SS, Miller JF. Craft N, et al. J Invest Dermatol. 2005 Jul;125(1):159-165. doi: 10.1111/j.0022-202X.2005.23759.x. J Invest Dermatol. 2005. PMID: 15982316 Free PMC article.

9

The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine.

Craft N, Bruhn KW, Nguyen BD, Prins R, Lin JW, Liau LM, Miller JF. Craft N, et al. J Immunol. 2005 Aug 1;175(3):1983-90. doi: 10.4049/jimmunol.175.3.1983. J Immunol. 2005. PMID: 16034143

10

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment.

Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin JW, Chute DJ, Mischel PS, Cloughesy TF, Roth MD. Liau LM, et al. Among authors: prins rm. Clin Cancer Res. 2005 Aug 1;11(15):5515-25. doi: 10.1158/1078-0432.CCR-05-0464. Clin Cancer Res. 2005. PMID: 16061868 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page